1Garg A, Dyslipoproteinemia and Diabetes, Endocri &Metab Clin Nor Am 1998;27(3):613-625.
2UK Prospective Diabetes Study Group, Hight blood pressure control and risk of macrovascular and microvascular complication in type 2 diabetes:UKPDS 38, BMJ 1998;317:703-713.
3Austin MA, Hokanson JE, Edwards KL, Hypertriglyceridemia as a Cardiovascular Risk Factor. Am J Cardiol 1998;81(4A) :78- 12B.
4Grundy SM. Hypertriglyceridemia, Atherogenic Dyslipidemia, and the Metabolic Syndrome. Am J Cardiol 1998; 81(4A) : 18B- 25B.
5Ginsberg HN. Effects of Statins on Triglyceride Metabolism. Am J Cardiol 1998;81(4A):32B-35B.
6Stein EA, Lane M, Laskarzewski P. Comparison of Statins in Hypertriglyceridemia, Am J Cardiol 1998 ; 81 (4A) : 66b-69B.
7Byington RP, Davis BR, Plehn JF et al, Redction of Stroke Events With Pravastatin. Circulation 2001 ; 103:387-392.
8Freeman DJ, Norrie J, Sattar N, et al. Pravastatin and the Development of Diabetes Mellitus. Circulation 2001 ; 357- 362.
同被引文献17
1McGarry JD.Dysregulation of fatty acid merabolism inrhe etiology of type 2.diabetes,2001, 50 (Suppl2): 6-8.
2Laakso M, Lehto S, Penttila I, et al. Mortlity from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction,Neng J Med,1998, 339:229-234.
3Turner RC, Millns H, Neil HA, et al.Risk faetros for coronary artery disease in non-insulin dependent diabetes mellitus (UKPDS: 23) .BMJ, 1998, 316: 823-823.
4Howard BV, Robbins DC, Sievers ML, et al. LDL cholesterol as a strong predictor of coronary heart' disease in diabetic individuals with insulin resistance and low LDL: the Strong Heart Study: Arterioscler Thromb Vase Biol, 2000, 20:830-835.
5Pyorala K, Pederson TR, KjekshusJ, et al.For the Scandinavian Simvestatin Survival study: Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinvavian Simvastation Survival Study (4S) .Diabetes Care 1997, 20:614-620.
6Grover SA, Coupal L, Zowall H, Dorais. Cost effectiveness of treating hyperlipidemia in the presence of diabetes : who should be treated? Circulation, 2000, 102 (7) :722-727.
